tolevamer
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00466635)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Toxin BBINDING AGENT
Toxin B binding agent
- Toxin ABINDING AGENT
Toxin A binding agent
- Clostridium difficileINHIBITOR
Clostridium difficile inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108655 ↗
Also known as
- gt267-004
- tolevamer potassium sodium
- tolevamer potassium sodium
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00466635 | Phase 3 | Apr 1, 2007 | Genzyme |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genzyme | For profit | 1 | 1 | 1 | 2007 |
1 organizations
Page 1 / 1